Wixela Inhub | Fluticasone Propionate And Salmeterol Powder Breastfeeding
Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Wixela Inhub | Fluticasone Propionate And Salmeterol Powder while breast-feeding.

What is Wixela Inhub | Fluticasone Propionate And Salmeterol Powder used for?


Wixela™ Inhub™ is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for: •Twice-daily treatment of asthma in patients aged 4 years and older. (1.1) •Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). (1.2) Important limitation of use: Not indicated for relief of acute bronchospasm. (1.1, 1.2) 1.1 Treatment of Asthma Wixela™ Inhub™ is indicated for the twice-daily treatment of asthma in patients aged 4 years and older. Wixela™ Inhub™ should be used for patients not adequately controlled on a long-term asthma control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonist (LABA). Important Limitation of Use Wixela™ Inhub™ is NOT indicated for the relief of acute bronchospasm. 1.2 Maintenance Treatment of Chronic Obstructive Pulmonary Disease Wixela™ Inhub™ 250/50 is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Wixela™ Inhub™ 250/50 is also indicated to reduce exacerbations of COPD in patients with a history of exacerbations. Wixela™ Inhub™ 250/50 twice daily is the only approved dosage for the treatment of COPD because an efficacy advantage of the higher strength Wixela™ Inhub™ 500/50 over Wixela™ Inhub™ 250/50 has not been demonstrated. Important Limitation of Use Wixela™ Inhub™ is NOT indicated for the relief of acute bronchospasm.

Can I continue breastfeeding if I am using Wixela Inhub | Fluticasone Propionate And Salmeterol Powder? How long does it stays in breast milk?

Wixela Inhub | Fluticasone Propionate And Salmeterol Powder safe for breastfeeding
There are 2 main ingredients of Wixela Inhub | Fluticasone Propionate And Salmeterol Powder, Fluticasone propionate and Salmeterol. One by one we have analyzed both Fluticasone propionate and Salmeterol for its impact on breastfeeding and based on our analysis we can conclude that Wixela Inhub | Fluticasone Propionate And Salmeterol Powder is safe to use in breastfeeding. We recommend you to check our analysis of Fluticasone propionate and Salmeterol as below.

Wixela Inhub | Fluticasone Propionate And Salmeterol Powder Breastfeeding Analsys


Fluticasone propionate while Breastfeeding

Safe

CAS Number: 90566-53-3

At latest update no relevant data on this subject were found in connection with breastfeeding, however, its low systemic absorption rate with a high plasma protein-binding capacity makes that excretion into breast milk may be very unlikely. Experts on this field consider topical, oral or inhaled steroids compatible with breastfeeding. At usual dose of oral, inhaled (nasal or pulmonary) or dermatologic preparations are used, absorption is very low with non-significant levels achieved in plasma serum. Whenever a treatment for eczema or dermatitis of the nipple is required, the least potent preparation should be used. Apply after a breast feed to let it to disappear before the next feed. Clear out excess of cream with a gauze when indicated. Avoid continuous use for longer than a week. Steroid toxicity has occurred in an infant after continuous use of steroidal cream on the nipple. Avoid use of creams, gels and other topical medication containing paraffin (petroleum-derived mineral oil) in order to avoid the risk of absorption by the child.

Salmeterol while Breastfeeding

Safe

CAS Number: 89365-50-4

Wixela Inhub | Fluticasone Propionate And Salmeterol Powder and breastfeeding

Long-acting bronchodilator.

 At latest update no published data on excretion into breastmilk were found.

 Because of a high plasma protein-binding capacity and very low or undetectable plasma concentrations observed after inhalation (Cazzola 2002, AEMPS 2012) the excretion into breastmilk in significant amounts is unlikely.
Its low oral bioavailability would hamper the pass to the infant’s plasma through the breastmilk ingested.

 Experts and scientific societies consider the use of Salmeterol during breastfeeding as devoid of risk for the infant (Ellsworth 1994, McDonald 1996, Nelson 2001, National Asthma Education 2004).

 Terbutaline (see specific info), a molecule related to the same group of drugs, is excreted in non-significant amounts into breastmilk.


Wixela Inhub | Fluticasone Propionate And Salmeterol Powder Breastfeeding Analsys - 2


Fluticasone propionate while Breastfeeding

CAS Number: 90566-53-3

Topical fluticasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breastfed infant by passage into breastmilk. However, it would be prudent to use the least potent drug on the smallest area of skin possible. It is particularly important to ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only the lower potency corticosteroids should be used on the nipple or areola where the infant could directly ingest the drugs from the skin. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[1] Any topical corticosteroid should be wiped off thoroughly prior to nursing if it is being applied to the breast or nipple area.

Salmeterol while Breastfeeding

CAS Number: 89365-50-4

Although no published data exist on the use of salmeterol by mouth or inhaler during lactation, data from the related drug, terbutaline, indicate that very little is expected to be excreted into breastmilk.[1] The authors of several reviews agree that use of inhaled bronchodilators is acceptable during breastfeeding because of the low bioavailability and maternal serum levels after use.[2][3][4][5]


Is Wixela Inhub | Fluticasone Propionate And Salmeterol Powder safe while breastfeeding

I am nursing mother and I have already used Wixela Inhub | Fluticasone Propionate And Salmeterol Powder, what should I do?

As usage of Wixela Inhub | Fluticasone Propionate And Salmeterol Powder is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Wixela Inhub | Fluticasone Propionate And Salmeterol Powder else no further action is required.


My health care provider has asked me to use Wixela Inhub | Fluticasone Propionate And Salmeterol Powder, what to do?

Usage of Wixela Inhub | Fluticasone Propionate And Salmeterol Powder is safe for nursing mothers and baby, No worries.


If I am using Wixela Inhub | Fluticasone Propionate And Salmeterol Powder, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Wixela Inhub | Fluticasone Propionate And Salmeterol Powder in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients